FAC Explorer

Finding 962018 (2023-001)

Significant Deficiency Repeat Finding
Requirement
N
Questioned Costs
-
Year
2023
Accepted
2024-03-27
Audit: 298311
Organization: Clarkson College (NE)
Auditor: Cliftonlarsonallen LLP

AI Summary

  • Core Issue: The College inaccurately reported the enrollment status of a student to NSLDS, leading to potential compliance violations.
  • Impacted Requirements: Institutions must report accurate enrollment statuses and certify them every 60 days, as per 34 CFR 682.610.
  • Recommended Follow-Up: The College should improve its reporting procedures and ensure only eligible students receive Title IV aid.

Finding Text

2023 – 001 Federal Agency: U.S. Department of Education Federal Program Title: Student Financial Aid Assistance Listing Number: Student Financial Aid Cluster Award Period: July 1, 2022, to June 30, 2023 Type of Finding: - Significant Deficiency in Internal Control Over Compliance - Other Matters Criteria or Specific Requirement: The Code of Federal Regulations, 34 CFR 682.610, states that institutions must report accurately the enrollment status of all students regardless if they receive aid from the institution or not. This includes the enrollment effective date and related enrollment status, which must be reported for both the Campus-Level and the Program-Level. In addition, at a minimum, schools are required to certify enrollment every 60 days, and respond within 15 days of the date that NSLDS sends a Roster file to the school or its third-party servicer. Condition: During our testing, we noted 1 of the 17 students enrollment status per institution's record did not match what was reported to NSLDS. This student also was not enrolled in a program eligible for Title IV aid yet was included in the aid listing and received aid during the year. Questioned Costs: None Context: During our testing, we noted the College did not have proper procedures in place to verify the reports sent to NSLDS are including accurate and correct information. Cause: The College processes and controls did not ensure that student status changes were properly reported to NSLDS. The effective date should be the student's last date of attendance and academically-related activity. In addition, students that are enrolled in programs not eligible for title IV aid should not be eligible to receive aid and there is not a safeguard to prevent this from happening. Effect: The NSLDS system is not updated with the correct student information which can cause a student to not properly enter the repayment period. In addition, students that are not eligible to receive aid may receive aid which can cause title IV aid to not be spent in ways the college is not supposed to spend it. Repeat Finding: Yes, see finding 2022-002. Recommendation: We recommend the College review its reporting procedures to ensure the students' statuses are accurately reported to NSLDS as required by regulations and they review who aid is given to, ensuring only those in title IV eligible programs are receiving aid. Views of Responsible Officials: There is no disagreement with the audit finding.

Categories

Student Financial Aid Internal Control / Segregation of Duties Reporting Significant Deficiency

Other Findings in this Audit

  • 385528 2023-001
    Significant Deficiency Repeat
  • 385529 2023-002
    Significant Deficiency Repeat
  • 385530 2023-003
    Significant Deficiency
  • 385531 2023-004
    Significant Deficiency
  • 385532 2023-005
    Significant Deficiency
  • 385533 2023-006
    Significant Deficiency Repeat
  • 385534 2023-007
    Significant Deficiency Repeat
  • 385535 2023-008
    Significant Deficiency
  • 385536 2023-001
    Significant Deficiency Repeat
  • 385537 2023-002
    Significant Deficiency Repeat
  • 385538 2023-003
    Significant Deficiency
  • 385539 2023-004
    Significant Deficiency
  • 385540 2023-005
    Significant Deficiency
  • 385541 2023-006
    Significant Deficiency Repeat
  • 385542 2023-007
    Significant Deficiency Repeat
  • 385543 2023-008
    Significant Deficiency
  • 385544 2023-001
    Significant Deficiency Repeat
  • 385545 2023-002
    Significant Deficiency Repeat
  • 385546 2023-003
    Significant Deficiency
  • 385547 2023-004
    Significant Deficiency
  • 385548 2023-005
    Significant Deficiency
  • 385549 2023-006
    Significant Deficiency Repeat
  • 385550 2023-007
    Significant Deficiency Repeat
  • 385551 2023-008
    Significant Deficiency
  • 385552 2023-001
    Significant Deficiency Repeat
  • 385553 2023-002
    Significant Deficiency Repeat
  • 385554 2023-003
    Significant Deficiency
  • 385555 2023-004
    Significant Deficiency
  • 385556 2023-005
    Significant Deficiency
  • 385557 2023-006
    Significant Deficiency Repeat
  • 385558 2023-007
    Significant Deficiency Repeat
  • 385559 2023-008
    Significant Deficiency
  • 385560 2023-001
    Significant Deficiency Repeat
  • 385561 2023-002
    Significant Deficiency Repeat
  • 385562 2023-003
    Significant Deficiency
  • 385563 2023-004
    Significant Deficiency
  • 385564 2023-005
    Significant Deficiency
  • 385565 2023-006
    Significant Deficiency Repeat
  • 385566 2023-007
    Significant Deficiency Repeat
  • 385567 2023-008
    Significant Deficiency
  • 385568 2023-001
    Significant Deficiency Repeat
  • 385569 2023-002
    Significant Deficiency Repeat
  • 385570 2023-003
    Significant Deficiency
  • 385571 2023-004
    Significant Deficiency
  • 385572 2023-005
    Significant Deficiency
  • 385573 2023-006
    Significant Deficiency Repeat
  • 385574 2023-007
    Significant Deficiency Repeat
  • 385575 2023-008
    Significant Deficiency
  • 385576 2023-001
    Significant Deficiency Repeat
  • 385577 2023-002
    Significant Deficiency Repeat
  • 385578 2023-003
    Significant Deficiency
  • 385579 2023-004
    Significant Deficiency
  • 385580 2023-005
    Significant Deficiency
  • 385581 2023-006
    Significant Deficiency Repeat
  • 385582 2023-007
    Significant Deficiency Repeat
  • 385583 2023-008
    Significant Deficiency
  • 385584 2023-001
    Significant Deficiency Repeat
  • 385585 2023-002
    Significant Deficiency Repeat
  • 385586 2023-003
    Significant Deficiency
  • 385587 2023-004
    Significant Deficiency
  • 385588 2023-005
    Significant Deficiency
  • 385589 2023-006
    Significant Deficiency Repeat
  • 385590 2023-007
    Significant Deficiency Repeat
  • 385591 2023-008
    Significant Deficiency
  • 385592 2023-009
    Significant Deficiency Repeat
  • 385593 2023-010
    Significant Deficiency Repeat
  • 961970 2023-001
    Significant Deficiency Repeat
  • 961971 2023-002
    Significant Deficiency Repeat
  • 961972 2023-003
    Significant Deficiency
  • 961973 2023-004
    Significant Deficiency
  • 961974 2023-005
    Significant Deficiency
  • 961975 2023-006
    Significant Deficiency Repeat
  • 961976 2023-007
    Significant Deficiency Repeat
  • 961977 2023-008
    Significant Deficiency
  • 961978 2023-001
    Significant Deficiency Repeat
  • 961979 2023-002
    Significant Deficiency Repeat
  • 961980 2023-003
    Significant Deficiency
  • 961981 2023-004
    Significant Deficiency
  • 961982 2023-005
    Significant Deficiency
  • 961983 2023-006
    Significant Deficiency Repeat
  • 961984 2023-007
    Significant Deficiency Repeat
  • 961985 2023-008
    Significant Deficiency
  • 961986 2023-001
    Significant Deficiency Repeat
  • 961987 2023-002
    Significant Deficiency Repeat
  • 961988 2023-003
    Significant Deficiency
  • 961989 2023-004
    Significant Deficiency
  • 961990 2023-005
    Significant Deficiency
  • 961991 2023-006
    Significant Deficiency Repeat
  • 961992 2023-007
    Significant Deficiency Repeat
  • 961993 2023-008
    Significant Deficiency
  • 961994 2023-001
    Significant Deficiency Repeat
  • 961995 2023-002
    Significant Deficiency Repeat
  • 961996 2023-003
    Significant Deficiency
  • 961997 2023-004
    Significant Deficiency
  • 961998 2023-005
    Significant Deficiency
  • 961999 2023-006
    Significant Deficiency Repeat
  • 962000 2023-007
    Significant Deficiency Repeat
  • 962001 2023-008
    Significant Deficiency
  • 962002 2023-001
    Significant Deficiency Repeat
  • 962003 2023-002
    Significant Deficiency Repeat
  • 962004 2023-003
    Significant Deficiency
  • 962005 2023-004
    Significant Deficiency
  • 962006 2023-005
    Significant Deficiency
  • 962007 2023-006
    Significant Deficiency Repeat
  • 962008 2023-007
    Significant Deficiency Repeat
  • 962009 2023-008
    Significant Deficiency
  • 962010 2023-001
    Significant Deficiency Repeat
  • 962011 2023-002
    Significant Deficiency Repeat
  • 962012 2023-003
    Significant Deficiency
  • 962013 2023-004
    Significant Deficiency
  • 962014 2023-005
    Significant Deficiency
  • 962015 2023-006
    Significant Deficiency Repeat
  • 962016 2023-007
    Significant Deficiency Repeat
  • 962017 2023-008
    Significant Deficiency
  • 962019 2023-002
    Significant Deficiency Repeat
  • 962020 2023-003
    Significant Deficiency
  • 962021 2023-004
    Significant Deficiency
  • 962022 2023-005
    Significant Deficiency
  • 962023 2023-006
    Significant Deficiency Repeat
  • 962024 2023-007
    Significant Deficiency Repeat
  • 962025 2023-008
    Significant Deficiency
  • 962026 2023-001
    Significant Deficiency Repeat
  • 962027 2023-002
    Significant Deficiency Repeat
  • 962028 2023-003
    Significant Deficiency
  • 962029 2023-004
    Significant Deficiency
  • 962030 2023-005
    Significant Deficiency
  • 962031 2023-006
    Significant Deficiency Repeat
  • 962032 2023-007
    Significant Deficiency Repeat
  • 962033 2023-008
    Significant Deficiency
  • 962034 2023-009
    Significant Deficiency Repeat
  • 962035 2023-010
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
84.268 Federal Direct Student Loans $10.40M
84.063 Federal Pell Grant Program $969,869
84.425 Education Stabilization Fund $622,240
93.364 Nursing Student Loans $564,197
93.264 Nurse Faculty Loan Program (nflp) $551,607
84.007 Federal Supplemental Educational Opportunity Grants $54,341
84.033 Federal Work-Study Program $11,574